Fig. 1From: Characteristics and outcomes for patients with advanced vaginal or vulvar cancer referred to a phase I clinical trials program: the MD Anderson cancer center experienceKaplan-Meier plots of survival in patients with metastatic vaginal cancer (n = 16; median, 6.2 months; 95 % CI, 3.7–8.8 months) and vulvar cancer (n–20; 4.6 months; 3.7–5.5 months)Back to article page